Articles related to GLP-1s

The combination of structured lifestyle interventions with targeted pharmacotherapy demonstrates significant potential for achieving substantial weight loss in patients with type 2 diabetes.

Ozempic (semaglutide) offers effective glycemic control and weight loss benefits for type 2 diabetes patients, but comes with a range of potential side effects. Physicians should be prepared to discuss common gastrointestinal issues, rare but serious complications, and special considerations for pregnant or postmenopausal patients.

Semaglutide medications, while effective for weight loss, may carry unexpected mental health risks that require careful monitoring and consideration in clinical practice.

Blood thinners interact with various medications and supplements, potentially increasing bleeding risk or reducing efficacy. Physicians should be aware of these interactions and educate patients on the importance of consulting healthcare professionals before taking new products.

Semaglutide may alter taste perception gene expression in the tongue and modify brain reactions to sweet tastes, potentially enhancing weight loss effects beyond appetite suppression.

Patients taking semaglutide for diabetes were more than four times more likely to develop NAION compared to those on other diabetes medications, while those using it for obesity had a seven-fold increased risk.